Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-26

Clinical Trial Update: Dexamethasone Before Elective Cesarean Section at Term in Reducing Neonatal Respiratory Distress Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the impact of dexamethasone given before elective cesarean section at term on neonatal respiratory distress syndrome outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Ain Shams University | Conditions: C08.381.840.500.475, C08.381.840.500.737 | Phase 4 | Status: UNKNOWN